Drug profile

The FDA adverse-event record for Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids

61 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids. Species, reactions, and outcomes follow.

#1011 of 2,679
by report volume (all drugs)
61
adverse-event reports
3.3%
death-coded share
Dog
most-reported species

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids ranks #1004 of 2679 by total reports (61) and #894 of 1130 by death-coded share (3.3%). National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#1004
This drug, reports of 2679
#894
This drug, death share of 1130

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids has 61 reports now versus 61 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids changes

Signature read: Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids's 3.3% death-coded share is among the lowest in the openFDA drug corpus.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
61
Total Reports
2
Deaths Reported
3.3%
Death-coded share of reports

Active Ingredients

Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids

Administration Routes

OralUnknown

Species Affected

Dog 61

Most Affected Breeds

Retriever - Labrador 6
Terrier (unspecified) 5
Shepherd Dog - German 4
Retriever - Golden 3
Pug 3
Beagle 3
Collie - Border 3
Retriever (unspecified) 2
Boxer (German Boxer) 2
Poodle - Toy 2

Most Reported Reactions

Emesis 18
Vomiting 11
Lack of efficacy - NOS 8
Lethargy (see also Central nervous system depression in 'Neurological') 7
Diarrhoea 7
Decreased appetite 5
Elevated liver enzymes 5
INEFFECTIVE, ANTIINFLAMMATORY 5
Other abnormal test result NOS 4
Lymphopenia 4
Behavioural disorder NOS 3
Lack of efficacy (endoparasite) - hookworm 3

Outcome Breakdown

Recovered/Normal
27 (44.3%)
Outcome Unknown
19 (31.1%)
Ongoing
9 (14.8%)
Recovered with Sequela
4 (6.6%)
Died
1 (1.6%)
Euthanized
1 (1.6%)

Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids: low death-coded share in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Nationwide drugs with similar profiles

Two openFDA-derived peer sets for Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids, both floored at ≥50 reports so the neighborhoods stay in the advertised mass.

What to do with this drug

  • Compare Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids's report volume and death-coded share against similar drugs nationwide. See similar drugs
  • Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
  • Browse the full drug directory to compare report counts across products. All drugs

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids (#1011 of 2,679 by report volume); death-coded 3.3%. PlainBreed drug row · death-coded share stamp 3.3% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →